Search Results for: AstraZeneca
R&D
A new player emerges in the non-small cell lung cancer (NSCLC) therapy scene
2018-10-11
Fruquintinib becomes the first homegrown oncology drug approved in China for major indication
2018-09-11
PARP inhibitors in cancer – BRCA or no BRCA
2018-07-03
1 20 21 22
Scroll to Top